| |
TTD
Drug ID:
DAP000999
| Drug
Information |
| Name | Cinoxacin | | Synonyms | ST044511; Azolinic Acid; NCGC00023754-04; EINECS 249-133-8; DB00827; Compound 64716; HMS500P20; Cinoxacine; NCGC00023754-03; UNII-LMK22VUH23; AC1L1EEQ; NSC304467; Oprea1_131085; Cinobactin; NCGC00023754-06; Lopac-C-8645; Prestwick3_000780; 1-Ethyl-6,7-methylenedioxy-4(1H)-oxocinnoline-3-carboxylic acid; Uronorm; KBio3_001263; KBio2_000632; Cinoxacine [INN-French]; NCGC00023754-05; C8645_SIGMA; (1,3)Dioxolo(4,5-g)cinnoline-3-carboxylic acid, 1-ethyl-1,4-dihydro-4-oxo-; MolPort-001-794-447; (1,3)Dioxolo(4,5-g)cinnoline-3-carboxylic acid, 1,4-dihydro-1-ethyl-4-oxo-; 1-Ethyl-1,4-dihydro-4-oxo(1,3)dioxolo(4,5-g)cinnoline-3-carboxylic acid; KBio1_000318; KBioSS_000632; cinoxacin; Cinoxacin [USAN:BAN:INN:JAN]; BRD-K14704277-001-05-1; Lopac0_000309; Lilly 64716; D00872; Spectrum_000152; BSPBio_000860; Cinoxacinum; LS-62687; Cinobac; SPECTRUM1500190; EU-0100309; NCGC00015277-04; SPBio_000360; Spectrum2_000570; SPBio_002799; BPBio1_000946; NSC 304467; NCGC00015277-01; Prestwick0_000780; NINDS_000318; AC1Q317Y; BRN 1084304; KBio2_003200; 1-Ethyl-1,4-dihydro-4-oxo[1,3]dioxolo[4,5-g]cinnoline-3-carboxylic acid; Prestwick1_000780; C08052; Spectrum5_000749; CCRIS 8206; NCGC00023754-07; CHEBI:3716; 1-Ethyl-4-oxo-1,4-dihydro[1,3]dioxolo[4,5-g]cinnoline-3-carboxylic acid; NCGC00015277-14; 28657-80-9; KBio2_005768; Clinoxacin; TNP00246; NCGC00015277-02; Prestwick2_000780; C12H10N2O5; Spectrum3_000352; BSPBio_002043; NCGC00015277-03; MLS001148076; SMR000058232; CHEMBL1208; HMS2091E18; [1,3]Dioxolo[4,5-g]cinnoline-3-carboxylic acid, 1-ethyl-1,4-dihydro-4-oxo-; DivK1c_000318; 1-ethyl-4-oxo-[1,3]dioxolo[4,5-g]cinnoline-3-carboxylic acid; C 8645; CAS-28657-80-9; Spectrum4_000289; IDI1_000318; Cinoxacinum [INN-Latin]; Prestwick_239; Cinoxacino [INN-Spanish]; KBioGR_000818; NCGC00015277-07; MLS000069630; Cinoxacin (JAN/USP/INN); CID2762; Cinoxacino; HMS1920O11; Cinx; HMS1570K22; Cinobac (TN) | | Indication | Urinary tract infections | Approved [1] | | Structure |
Click to save drug structure in 3D MOL format
Click to save drug structure in 2D MOL format | | Therapeutic Class | Antiinfective Agents | | CAS Number | CAS 28657-80-9 | | Formular | C12H10N2O5 | | PubChem Compound ID | CID 2762. | | PubChem Substance ID | SID 10252. | | SuperDrug ATC ID | J01MB06; | | SuperDrug CAS ID | 028657809; | | Target | DNA gyrase |  | Inhibitor | [2] | | Ref 1 | FDA Approved Drug Products from FDA Official Website. 2009. Application Number: (NDA) 018067 To Reference | | Ref 2 | The interaction and transport of beta-lactam antibiotics with the cloned rat renal organic anion transporter 1. J Pharmacol Exp Ther. 1999 Aug;290(2):672-7. To Reference |
Welcome
to sign our Guestbook.
If you
find any error in data or bug in web service, please kindly report it
to Dr.
Zhu.
Dr.
Chen Yuzong
Deputy Director of Center
for Computational Science and Engineering
Professor in Department of Pharmacy
National University of Singapore, Singapore
All rights reserved.
|
|